PMID- 18521456 OWN - NLM STAT- MEDLINE DCOM- 20080926 LR - 20161124 IS - 0379-5284 (Print) IS - 0379-5284 (Linking) VI - 29 IP - 6 DP - 2008 Jun TI - Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population. PG - 808-12 AB - OBJECTIVE: To assess the frequency of 2 different forms of hemochromatosis HFE gene mutations (C282Y and H63D mutations) in a normal population in comparison with type 2 diabetic patients. METHODS: This case control study was undertaken in Zanjan Diabetic Care Center, Zanjan, western Tehran, in 2005. Two hundred and two individuals were included in this study: 101 type 2 diabetes mellitus (T2DM) patients, and 101 age, and gender-matched controls. The patients were examined for mutations in the HFE gene. Nucleotide 845 (C282Y) and 187 (H63D) alleles were amplified by polymerase chain reaction PCR with lymphocyte deoxy-ribonucleic acid. The PCR products were analyzed by restriction enzyme digestion. Chi-square, student's t test, and Fisher's exact tests were used for comparison, and odds' ratio was calculated. RESULTS: Two hundred and two individuals were studied. The frequency of wild/C282Y alleles was 98/2% in T2DM patients, and 99/1% in controls p=0.6. The frequency of wild/H63D alleles was 68.3/31.7% in diabetics p=0.08, and 73.4/26.3% in control subjects p=0.08. The distribution of genotypes was not statistically different. CONCLUSION: Based on our data, HFE mutations were not found in excess in patients with T2DM, and there was no evidence that a population-based search for an excess of these alleles in type 2 diabetes was indicated. FAU - Sharifi, Faranak AU - Sharifi F AD - Department of Endocrinology, Vali-e-asr Hospital, Zanjan Metabolic Diseases Research Center, Zanjan, Iran. faranaksharifi@hotmail.com FAU - Esmaeilzadeh, Abdulreza AU - Esmaeilzadeh A FAU - Zali, Mohammadreza AU - Zali M LA - eng PT - Journal Article PL - Saudi Arabia TA - Saudi Med J JT - Saudi medical journal JID - 7909441 RN - 0 (HFE protein, human) RN - 0 (Hemochromatosis Protein) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Proteins) SB - IM MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*genetics MH - Female MH - Hemochromatosis Protein MH - Histocompatibility Antigens Class I/*genetics MH - Humans MH - Iran MH - Male MH - Membrane Proteins/*genetics MH - Middle Aged MH - Mutation MH - Polymerase Chain Reaction EDAT- 2008/06/04 09:00 MHDA- 2008/09/27 09:00 CRDT- 2008/06/04 09:00 PHST- 2008/06/04 09:00 [pubmed] PHST- 2008/09/27 09:00 [medline] PHST- 2008/06/04 09:00 [entrez] AID - 20080037' [pii] PST - ppublish SO - Saudi Med J. 2008 Jun;29(6):808-12.